{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:49:26Z","timestamp":1767851366550,"version":"3.49.0"},"reference-count":14,"publisher":"American Academy of Pediatrics (AAP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:p>Neonates presenting with seizures are frequently assessed and managed by neonatologists in the NICU. Although hypoxic-ischemic encephalopathy and infection are common underlying causes of neonatal seizures, many patients with neonatal epilepsy will have an identifiable genetic etiology. Often these cases will be evaluated in collaboration with a geneticist. The categories of genetic causes of neonatal seizures include 1) structural brain malformations; 2) inborn errors of metabolism; 3) syndromic; and 4) nonsyndromic, single gene. Evaluation of these patients involves a comprehensive history and examination, followed by appropriate investigations and diagnostic genetic testing. Components of the diagnostic process will vary based on the clinical suspicion and differential diagnoses. In certain cases, syndromic surveillance for evaluation of other congenital anomalies may be recommended. Determination of the underlying genetic diagnosis, when present, will have important implications for treatment. Targeted therapies are currently available for specific genetic syndromes, and outcomes may improve with earlier initiation of therapy. Certain genetic diagnoses may also have guideline-based management involving screening for other manifestations of the disorder.<\/jats:p>","DOI":"10.1542\/neo.21-10-e663","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T13:23:41Z","timestamp":1601558621000},"page":"e663-e672","source":"Crossref","is-referenced-by-count":10,"title":["Genetic Etiologies of Neonatal Seizures"],"prefix":"10.1542","volume":"21","author":[{"given":"Shagun","family":"Kaur","sequence":"first","affiliation":[{"name":"Division of Genetic, Genomic, and Metabolic Disorders, Children\u2019s Hospital of Michigan, Detroit, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara","family":"Pappas","sequence":"additional","affiliation":[{"name":"Division of Genetic, Genomic, and Metabolic Disorders, Children\u2019s Hospital of Michigan, Detroit, MI"},{"name":"Department of Pediatrics, Central Michigan University, Mt Pleasant, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"issue":"9","key":"2021121000494480000_B1","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1212\/WNL.0000000000004284","article-title":"Profile of neonatal epilepsies: characteristics of a prospective US cohort","volume":"89","author":"Shellhaas","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"2021121000494480000_B2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejpn.2018.02.006","article-title":"Genetic diagnosis in neonatal-onset epilepsies: back to the future","volume":"22","author":"Pisani","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"issue":"10","key":"2021121000494480000_B3","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s00415-016-8225-x","article-title":"Clinical manifestations in children and adolescents with corpus callosum abnormalities","volume":"263","author":"Margari","year":"2016","journal-title":"J Neurol"},{"issue":"2","key":"2021121000494480000_B4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1684\/j.1950-6945.2005.tb00106.x","article-title":"Epilepsy in inborn errors of metabolism","volume":"7","author":"Wolf","year":"2005","journal-title":"Epileptic Disord"},{"issue":"1","key":"2021121000494480000_B5","first-page":"1","article-title":"Neonatal vitamin-responsive epileptic encephalopathies","volume":"33","author":"Gospe","year":"2010","journal-title":"Chang Gung Med J"},{"issue":"20","key":"2021121000494480000_B6","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1212\/WNL.0000000000003936","article-title":"Phenotype of GABA-transaminase deficiency","volume":"88","author":"Koenig","year":"2017","journal-title":"Neurology"},{"issue":"10","key":"2021121000494480000_B7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11910-016-0694-x","article-title":"Recent advances in neonatal seizures","volume":"16","author":"Sands","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"2021121000494480000_B8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13041-018-0392-5","article-title":"Novel and de novo mutations in pediatric refractory epilepsy","volume":"11","author":"Liu","year":"2018","journal-title":"Mol Brain"},{"issue":"4","key":"2021121000494480000_B9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/0883073815599262","article-title":"Diagnostic approach to genetic causes of early-onset epileptic encephalopathy","volume":"31","author":"G\u00fcrsoy","year":"2016","journal-title":"J Child Neurol"},{"issue":"3","key":"2021121000494480000_B10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.siny.2018.01.003","article-title":"Neonatal epilepsy genetics","volume":"23","author":"Axeen","year":"2018","journal-title":"Semin Fetal Neonatal Med"},{"issue":"3","key":"2021121000494480000_B11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ana.23600","article-title":"Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development","volume":"72","author":"Forcelli","year":"2012","journal-title":"Ann Neurol"},{"issue":"8","key":"2021121000494480000_B12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/adc.2007.116913","article-title":"Treatable neonatal epilepsy","volume":"92","author":"Surtees","year":"2007","journal-title":"Arch Dis Child"},{"issue":"3","key":"2021121000494480000_B13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neurol.2016.02.005","article-title":"Severe neonatal seizures: from molecular diagnosis to precision therapy?","volume":"172","author":"Milh","year":"2016","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"2021121000494480000_B14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/epi.13676","article-title":"Neonatal nonepileptic myoclonus is a prominent clinical feature of KCNQ2 gain-of-function variants R201C and R201H","volume":"58","author":"Mulkey","year":"2017","journal-title":"Epilepsia"}],"container-title":["NeoReviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/21\/10\/e663\/822665\/neoreviews_032020o00027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/21\/10\/e663\/822665\/neoreviews_032020o00027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T07:41:14Z","timestamp":1723707674000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/neoreviews\/article\/21\/10\/e663\/87348\/Genetic-Etiologies-of-Neonatal-Seizures"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":14,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,1]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/neo.21-10-e663","relation":{},"ISSN":["1526-9906"],"issn-type":[{"value":"1526-9906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}